• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage

July 28, 2025

Do You Have the Finances of an Average American?

July 28, 2025

8 Surprising Household Items You Can Sell for Fast Cash

July 28, 2025
Facebook Twitter Instagram
Trending
  • Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage
  • Do You Have the Finances of an Average American?
  • 8 Surprising Household Items You Can Sell for Fast Cash
  • This Mindset Can Protect Your Business From Costly Mistakes
  • How the Next Generation of Entrepreneurs Is Outpacing Us — and Why
  • More Than 1,000 Business and Tech Courses Can Be Yours Forever for Just $20
  • Learn How to Use ChatGPT to Automate Your Business
  • What You Need To Know About The New Retirement Account RMD Penalty
Monday, July 28
Facebook Twitter Instagram
iSafeSpend
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
iSafeSpend
Home » Bayer says guidance cut driven by Crop Science, Pharma
Investing

Bayer says guidance cut driven by Crop Science, Pharma

News RoomBy News RoomAugust 8, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

© Reuters. FILE PHOTO: The logo of Bayer AG is pictured at the facade of the historic headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay/File Photo

By Ludwig Burger

FRANKFURT (Reuters) -Bayer said on Tuesday that last month’s cut to its full-year earnings target was mainly driven by a bleaker outlook at its Crop Science division and by expectations for flat pharmaceuticals sales.

The German drugs and pesticides maker said in unscheduled statement last month that it was projecting 2023 group earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, to be in a range of 11.3 billion euros ($12.5 billion) and 11.8 billion euros on a currency-adjusted basis, down from 13.5 billion euros reported for 2022.

It specified in a statement on Tuesday that the adjusted EBITDA margin over 2023 sales at the agriculture business known as Crop Science would be about 21%, down from 25% projected in May.

Currency-adjusted divisional sales would be down by about 5% and not up by about 1.5% as previously seen.

CEO Bill Anderson, a former Roche executive, has had a challenging start since he took the top job in June. Bayer (OTC:)’s main agriculture business has been hurt by cost inflation, dry weather weighing on farmers’ demand, and by a slump in prices of glyphosate-based weedkillers from last year’s highs when revenues were inflated by rivals’ production outages.

Prescription drug sales would be flat and not up by about 1% as previously targeted, with the profit margin seen at about 28% this year, down from a previous goal of more than 29%.

Sales of non-prescription consumer health products, the smallest of Bayer’s three divisions, were still seen up 5% this year.

Bayer also reported a net loss of 1.89 billion euros for the second quarter, weighed down by 2.3 billion euros in impairment charges.

It had previously cited preliminary figures as showing expected goodwill impairments worth about 2.5 billion euros, leading to a second-quarter net loss of 2 billion euros.

Read the full article here

Featured
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Do You Have the Finances of an Average American?

Burrow July 28, 2025

8 Surprising Household Items You Can Sell for Fast Cash

Make Money July 28, 2025

This Mindset Can Protect Your Business From Costly Mistakes

Make Money July 27, 2025

How the Next Generation of Entrepreneurs Is Outpacing Us — and Why

Investing July 27, 2025

More Than 1,000 Business and Tech Courses Can Be Yours Forever for Just $20

Make Money July 27, 2025

Learn How to Use ChatGPT to Automate Your Business

Make Money July 27, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Do You Have the Finances of an Average American?

July 28, 20250 Views

8 Surprising Household Items You Can Sell for Fast Cash

July 28, 20250 Views

This Mindset Can Protect Your Business From Costly Mistakes

July 27, 20250 Views

How the Next Generation of Entrepreneurs Is Outpacing Us — and Why

July 27, 20250 Views
Don't Miss

More Than 1,000 Business and Tech Courses Can Be Yours Forever for Just $20

By News RoomJuly 27, 2025

Disclosure: Our goal is to feature products and services that we think you’ll find interesting…

Learn How to Use ChatGPT to Automate Your Business

July 27, 2025

What You Need To Know About The New Retirement Account RMD Penalty

July 27, 2025

Are You Working to Live or Just to Cover the Rent?

July 27, 2025
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: support@isafespend.com

Our Picks

Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage

July 28, 2025

Do You Have the Finances of an Average American?

July 28, 2025

8 Surprising Household Items You Can Sell for Fast Cash

July 28, 2025
Most Popular

Why Make Year-End Charitable Donations?

August 6, 20235 Views

More than half of Gen Xers stopped saving for retirement, here’s why: Survey

August 5, 20233 Views

Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage

July 28, 20250 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 iSafeSpend. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.